logo-loader
ASX:SPL

Starpharma Holdings Limited

Receive alerts
Market:
ASX
Market Cap:
$421.9 m
Price
$1.14
Change
1.34%
52 weeks high
1.66
52 weeks low
0.87

Filter by article type

Viewing results 1-17 of 17

Health

Starpharma signs licence for US commercialisation of VivaGel BV therapy

The deal will enable Starpharma to leverage its treatment product with growing demand in the US for new and non-antibiotic therapies....

on 20/12/18
Health

Starpharma Holdings' cabazitaxel is second DEP product to enter clinical stage

DEP® cabazitaxel has already delivered impressive pre-clinical results....

on 31/1/18
Health

Starpharma soars on “very exciting” ovarian cancer results

Starpharma are already up 24%, in Australia, after its potential treatment outperformed existing drugs in a model...

on 17/11/15